BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 18418417)

  • 1. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus mediated gene therapy for retinal degenerative diseases.
    Stieger K; Cronin T; Bennett J; Rolling F
    Methods Mol Biol; 2011; 807():179-218. PubMed ID: 22034031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
    Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
    Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for gene therapy of inherited retinal disease.
    Bainbridge JW
    Eye (Lond); 2009 Oct; 23(10):1898-903. PubMed ID: 19151647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The development in the studies of AAV-mediated gene therapy in retina].
    Zou X; Sui RF; Dong FT
    Zhonghua Yan Ke Za Zhi; 2011 Nov; 47(11):1049-52. PubMed ID: 22336072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats.
    Ikeda Y; Goto Y; Yonemitsu Y; Miyazaki M; Sakamoto T; Ishibashi T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K
    Gene Ther; 2003 Jul; 10(14):1161-9. PubMed ID: 12833125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
    Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
    Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
    Flannery JG; Visel M
    Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration.
    Jomary C; Vincent KA; Grist J; Neal MJ; Jones SE
    Gene Ther; 1997 Jul; 4(7):683-90. PubMed ID: 9282169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy progress and prospects: the eye.
    Bainbridge JW; Tan MH; Ali RR
    Gene Ther; 2006 Aug; 13(16):1191-7. PubMed ID: 16838031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-based gene transfer.
    Büning H; Nicklin SA; Perabo L; Hallek M; Baker AH
    Curr Opin Mol Ther; 2003 Aug; 5(4):367-75. PubMed ID: 14513679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of intraperitoneal administration as a route of AAV serotype 5 vector-mediated neonatal gene transfer.
    Ogura T; Mizukami H; Mimuro J; Madoiwa S; Okada T; Matsushita T; Urabe M; Kume A; Hamada H; Yoshikawa H; Sakata Y; Ozawa K
    J Gene Med; 2006 Aug; 8(8):990-7. PubMed ID: 16685745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
    Zaiss AK; Muruve DA
    Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.